Platinum levels and clinical responses of tumours treated by cisplatin with and without concurrent hyperthermia: a case study

References

• Alberts D. S., Peng Y-M., Chen H-S. G., Moon T. E., Cetas T. C., Hoeschele J. D. Therapeutic synergism of hyperthermia-cis-platinum in a mouse tumor model. Journal of the National Cancer Institute 1980; 65: 455–461
   PubMed Web of Science ®Google Scholar
• Colacchio T. A., Coughlin C., Taylor J., Douple E., Ryan T., Crichlow R. W. Intraoperative radiation therapy and hyperthermia. Archives of Surgery 1990; 125: 370–375
   PubMedGoogle Scholar
• Coughlin C. T., Richmond R. C. Biologic and clinical developments of cisplatin combined with radiation: concepts, utility, projections for new trials, and the emergence of carboplatin. Seminars in Oncology 1989; 16(Suppl. 6)31–43
   PubMed Web of Science ®Google Scholar
• Delves H. T., Shuttler I. L. Interferences in the measurement of platinum in body tissues and fluids using electrothermal atomization and atomic absorption spectrophotometry. Biochemical Mechanisms of Platinum Antitumour Drugs, D. C. H. McBrien, T. F. Slater. IRL Press, Washington, DC 1986; 329–347
   Google Scholar
• Douple E. B., Strohbehn J. W., van Sieyes D. C., Alborough D. P., Trembly B. S. Therapeutic potentiation of cisdichlorodiamnineplatinum(II) and radiation by interstitial microwave hyperthermia in a mouse tumor. National Cancer Institute Monograph 1982; 61: 259–262
   Google Scholar
• Eichholtz-Wirth H., Hietel B. Heat sensitization to cisplatin in two cell lines with different drug sensitivities. International Journal of Hyperthermia 1990; 6: 47–55
   PubMed Web of Science ®Google Scholar
• Engelhardt R., Muller U., Weth-Simon R., Neumann H. A., Lohr G. W. Treatment of disseminated malignant melanoma with cisplatin in combination with whole-body hyperthermia and doxorubicin. International Journal of Hyperthermia 1990; 6: 511–515
   PubMed Web of Science ®Google Scholar
• Fisher G. A., Hahn G. M. Enhancement of cis-platinum(II) diamminedichloride cytotoxicity by hyperthermia. National Cancer Institute Monograph 1982; 61: 255–257
   Google Scholar
• Gouyette A., Apchin A., Foka M., Richard J-M. Pharmacokinetics of intraarterial and intravenous cisplatin in head and neck cancer patients. European Journal of Cancer and Clinical Oncology 1986; 22: 257–263
   PubMedGoogle Scholar
• Green D. M., Burton G. V., Cox E. B., Hanson D., Moore F., Oleson J. R. A phase I/II study of combined cisplatin and hyperthermia treatment for refractory malignancy. International Journal of Hyperthermia 1989; 5: 13–21
   PubMed Web of Science ®Google Scholar
• Karakousis C. P., Holtermann O. A., Holyoke E. D. cis-Dichlorodiammine-platinum(II) in metastatic soft tissue sarcomas. Cancer Treatment Reports 1979; 63: 2071–2074
   PubMedGoogle Scholar
• Mattox D. E., Sternson L. A., van Hoff D. D., Kuhn J. G., Repta A. J. Tumor concentration of platinum in patients with head and neck cancer. Otolaryngology, Head and Neck Surgery 1983; 91: 271–275
   PubMed Web of Science ®Google Scholar
• Mavligit G. M., Benjamin R., Patt Y. Z., Jaffe N., Chuang V., Wallace S., Murray J., Ayala A., Johnston S., Hersh E. M., Calvo D. B. Intraarterial cis-platinum for patients with inoperable skeletal tumors. Cancer 1981; 48: 1–4
   PubMed Web of Science ®Google Scholar
• Meyn R. E., Corry P. M., Fletcher S. E., Demetriades M. Thermal enhancement of DNA damage in mammalian cells treated with cis-diamminedichloroplatinum(II). Cancer Research 1980; 40: 1136–1139
   PubMed Web of Science ®Google Scholar
• Neterman J., Wasserman W. Applied Linear Statistical Models, 2nd edn. R. D. Irwin, Homewood, Illinois 1985
   Google Scholar
• Ribaud P., Gouveia J., Bonnay M., Mathe G. Clinical pharmacology and pharmacokinetics of cis-platinum and analogs. Cancer Treatment Reports 1981; 65(Suppl. 3)97–105
   PubMedGoogle Scholar
• Riviere J. E., Page R. L., Rogers R. A., Chang S. K., Dewhirst M. W., Thrall D. E. Nonuniform alteration of cis-diamminedichloroplatinum(II) tissue distribution in dogs with whole body hyperthermia. Cancer Research 1990; 50: 2075–2080
   PubMed Web of Science ®Google Scholar
• Ryan T. P., Hartov A., Colacchio T. A., Coughlin C. T., Stafford J. H., Hoopes P. J. Analysis and testing of a concentric ring applicator for ultrasound hyperthermia with clinical results. International Journal of Hyperthermia 1991a; 7: 587–603
   PubMed Web of Science ®Google Scholar
• Ryan T. P., Wikoff R., Hoopes P. J. Design of an automated temperature mapping system for ultrasound or microwave hyperthermia. Journal of Biomedical Engineering 1991b; 13: 348–354
   PubMedGoogle Scholar
• Stewart D. J., Benjamin R. S., Luna M., Feun L., Caprioli R., Seifert W., Loo T. L. Human tissue distribution of platinum after cis-diamminedichloroplatinum. Cancer Chemotherapy and Pharmacology 1982; 10: 51–54
   PubMed Web of Science ®Google Scholar
• Urano M., Kahn J., Kenton L. A. The effect of cis-diamminedichloroplatinum(II) treatment at elevated temperatures on murine fibrosarcoma, FSa-II. International Journal of Hyperthermia 1990a; 6: 563–570
   PubMed Web of Science ®Google Scholar
• Urano M., Kahn J., Majima H., Gerwick L. E. The cytotoxic effect of cis-diamminedichloroplatinum(II) on cultured Chinese hamster ovary cells at elevated temperatures: Arrhenius plot analysis. International Journal of Hyperthermia 1990b; 6: 581–590
   PubMed Web of Science ®Google Scholar
• Wallner K. E., De Gregoria M. W., Li G. C. Hyperthermic potentiation of cis-diamminedichloroplatinum(II) cytotoxicity in Chinese hamster ovary cells resistant to the drug. Cancer Research 1986; 46: 6242–6245
   PubMed Web of Science ®Google Scholar